Varinos

About:

Varinos is a biotechnology company that offers new genomic testing and contract analysis services.

Twitter/X: varinosinc

Top Investors: SMBC Venture Capital, Angel Bridge, Fast Track Initiative, Inc., Miyako Capital

Description:

Varinos is a clinical laboratory contract analysis company that is a partner of medical institutions. Varinos provides genomic testing development and contract analysis services using the latest technology, the next-generation sequencer.

Total Funding Amount:

500M JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2017-02-20

Contact Email:

info(AT)varinos.com

Founders:

Yoshiyuki Sakuraba

Number of Employees:

11-50

Last Funding Date:

2022-08-03

IPO Status:

Private

Industries: